title: Keratinocyte growth factor and epidermal growth factor can reverse the intestinal atrophy associated with elemental diets in mice.
abstract: Elemental diets are associated with intestinal atrophy and reduced intestinal integrity. Growth factors such as keratinocyte growth factor (KGF) and epidermal growth factor (EGF) have considerable potential for the therapeutic reversal of such atrophy and may have greater actions if given in combination. We examined the effects of recombinant human KGF (rHuKGF), EGF and their combination on tissue mass, cell proliferation and crypt fission throughout the intestine of mice fed elemental diets. rHuKGF significantly increased the relative wet weight of the intestine, with EGF having a lesser effect. Cell proliferation of the stomach, small intestine and colon were significantly increased by rHuKGF, but EGF only increased proliferation in the small intestine. Crypt fission in the small intestine and colon was significantly decreased by rHuKGF. An interactive effect of rHuKGF and EGF on the weight of stomach and the proliferation of the fundus and antrum was observed. Moreover, an interactive effect of the agents was also seen on crypt fission in the colon. We concluded that (1) rHuKGF and EGF have significant trophic effects on the stomach, small intestine and colon, (2) these actions vary between different sites in the gastrointestinal tract, and (3) interactive effects occur.
authors.affiliation: Department of Internal Medicine, Shiga University of Medical Science, Seta-tsukinowa, Otsu, Shiga 520-2192, Japan.
authors.forename: Masaya
authors.initials: M
authors.lastname: Sasaki
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: FitzGerald
authors.forename: Nikki
authors.initials: N
authors.lastname: Mandir
authors.forename: Jorge
authors.initials: J
authors.lastname: Berlanga-Acosta
authors.forename: Robert A
authors.initials: RA
authors.lastname: Goodlad
mesh_terms: D000818:Animals; D001284:Atrophy; D002455:Cell Division / Q000187:drug effects; D003106:Colon / Q000473:pathology*; D004357:Drug Synergism; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors / Q000494:pharmacology*; D005526:Food, Formulated / Q000633:toxicity*; D007421:Intestine, Small / Q000473:pathology*; D008297:Male; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D011994:Recombinant Proteins / Q000494:pharmacology
chemical_list: C496454:Fgf7 protein, mouse; D011994:Recombinant Proteins; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors; D004815:Epidermal Growth Factor